UBS raises Covid-19 loss estimate to $30bn-$60bn on non-US BI fears

Analysts at UBS have raised their estimate of insured losses from the coronavirus pandemic to between $30bn and $60bn, from their previous range of $20bn to $40bn.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@thomsonreuters.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com